Lineage Cell Therapeutics Inc (NYSE American:LCTX)

1.48
Delayed Data
As of Dec 02
 0.00 / 0.00%
Today’s Change
1.02
Today|||52-Week Range
2.71
-39.59%
Year-to-Date
No recent news for Lineage Cell Therapeutics Inc.

Today’s Trading

Previous close1.48
Today’s open1.47
Day’s range1.44 - 1.49
Volume235,332
Average volume (3 months)340,439
Market cap$249.9M
Data as of 3:59pm ET, 12/02/2022

Growth & Valuation

Earnings growth (last year)-90.04%
Earnings growth (this year)+41.21%
Earnings growth (next 5 years)+3.00%
Revenue growth (last year)+404.01%
P/E ratioNM
Price/Sales103.45
Price/Book2.70

Competitors

 Today’s
change
Today’s
% change
XXII22nd Century Group I...0.000.00%
VYGRVoyager Therapeutics...+0.38+6.29%
----
OTLKOutlook Therapeutics...+0.03+2.86%
Data as of 4:00pm ET, 12/02/2022

Financials

Next reporting dateMarch 16, 2023
EPS forecast (this quarter)-$0.04
Annual revenue (last year)$3.9M
Annual profit (last year)-$43.0M
Net profit margin-1,104.18%

Profile

Sector
Health Technology
Industry
Biotechnology
No executives to display
Corporate headquarters
Carlsbad, California

Forecasts